Exact Mass: 652.3948132

Exact Mass Matches: 652.3948132

Found 28 metabolites which its exact mass value is equals to given mass value 652.3948132, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

dysoxin 3a

dysoxin 3a

C39H56O8 (652.3974976000001)


   

1-methoxy-7,8-dimethyl-beta-naphthyl-beta-D-glucopuranosyl-4-pimaran-17-oic acid ester

1-methoxy-7,8-dimethyl-beta-naphthyl-beta-D-glucopuranosyl-4-pimaran-17-oic acid ester

C39H56O8 (652.3974976000001)


   

2-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-butenyl)-5-[6-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-butenyl)-5-(2-methyl-1-oxopropyl)phenyl] heptyl]phenyl]-1-butanone

2-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-butenyl)-5-[6-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-butenyl)-5-(2-methyl-1-oxopropyl)phenyl] heptyl]phenyl]-1-butanone

C39H56O8 (652.3974976000001)


   

C39H56O8

C39H56O8 (652.3974976000001)


   

3-methoxy-6,8-dimethyl-beta-naphthyl-beta-D-glucopyranosyl-6-pimaran-17-oic acid ester|catharanthusopimaranoside A

3-methoxy-6,8-dimethyl-beta-naphthyl-beta-D-glucopyranosyl-6-pimaran-17-oic acid ester|catharanthusopimaranoside A

C39H56O8 (652.3974976000001)


   

lipidyl pseudopterane B

lipidyl pseudopterane B

C39H56O8 (652.3974976000001)


   

Amyloid β-Protein (16-20) trifluoroacetate salt

Amyloid β-Protein (16-20) trifluoroacetate salt

C35H52N6O6 (652.3948132)


β-Amyloid peptide(16-20) is a amino acid sequences (KLVFF) of Amyloid-β (Abeta). β-Amyloid peptide(16-20) is an effective inhibitor of Abeta fibril formation, with RG-/-GR-NH2 residues added at N- and C-terminal ends to aid solubility)[1].

   

Metoprolol succinate

Metroprolol succinate

C34H56N2O10 (652.3934756)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Metoprolol succinate is an orally active, selective β1-adrenoceptor antagonist. Metoprolol succinate shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].

   

Ethidium homodimer tetracation

Ethidium homodimer tetracation

C41H48N8+4 (652.4001728)


   

2-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H59NO8P+ (652.3978084)


   

2-[[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H59NO8P+ (652.3978084)


   

SQMG 23:1

SQMG 23:1

C32H60O11S (652.385613)


   

PG O-18:0/8:2;O2

PG O-18:0/8:2;O2

C32H61O11P (652.3951285999999)


   

PG O-26:2;O2

PG O-26:2;O2

C32H61O11P (652.3951285999999)


   

PG P-18:0/8:1;O2

PG P-18:0/8:1;O2

C32H61O11P (652.3951285999999)


   

PG 18:0/8:1;O

PG 18:0/8:1;O

C32H61O11P (652.3951285999999)


   

PG 22:0/4:1;O

PG 22:0/4:1;O

C32H61O11P (652.3951285999999)


   

PG 26:1;O

PG 26:1;O

C32H61O11P (652.3951285999999)


   

{3,4,5-trihydroxy-6-[(3-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-2-yl}methyl 7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

{3,4,5-trihydroxy-6-[(3-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-2-yl}methyl 7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

C39H56O8 (652.3974976000001)


   

methyl 8-hydroxy-7-(octadec-9-enoyloxy)-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-triene-12-carboxylate

methyl 8-hydroxy-7-(octadec-9-enoyloxy)-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-triene-12-carboxylate

C39H56O8 (652.3974976000001)


   

(2r)-1-{6-[(1r)-1-[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)-3,4-dihydro-1-benzopyran-6-yl]-6-methylheptyl]-5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl}-2-methylbutan-1-one

(2r)-1-{6-[(1r)-1-[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)-3,4-dihydro-1-benzopyran-6-yl]-6-methylheptyl]-5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl}-2-methylbutan-1-one

C39H56O8 (652.3974976000001)


   

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-(acetyloxy)-15-[(2s,3r,5s)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-(acetyloxy)-15-[(2s,3r,5s)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C39H56O8 (652.3974976000001)


   

1-(6-{1-[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)-3,4-dihydro-1-benzopyran-6-yl]-6-methylheptyl}-5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl)-2-methylbutan-1-one

1-(6-{1-[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)-3,4-dihydro-1-benzopyran-6-yl]-6-methylheptyl}-5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl)-2-methylbutan-1-one

C39H56O8 (652.3974976000001)


   

2-methyl-1-(2,4,6-trihydroxy-3-{6-methyl-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)phenyl]heptyl}-5-(3-methylbut-2-en-1-yl)phenyl)butan-1-one

2-methyl-1-(2,4,6-trihydroxy-3-{6-methyl-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)phenyl]heptyl}-5-(3-methylbut-2-en-1-yl)phenyl)butan-1-one

C39H56O8 (652.3974976000001)


   

methyl (2r,3r,7r,8r,9r)-8-hydroxy-7-[(9z)-octadec-9-enoyloxy]-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-triene-12-carboxylate

methyl (2r,3r,7r,8r,9r)-8-hydroxy-7-[(9z)-octadec-9-enoyloxy]-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-triene-12-carboxylate

C39H56O8 (652.3974976000001)


   

3-(acetyloxy)-15-[5-(1,2-dihydroxy-2-methylpropyl)-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

3-(acetyloxy)-15-[5-(1,2-dihydroxy-2-methylpropyl)-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C39H56O8 (652.3974976000001)


   

(2r)-2-methyl-1-{2,4,6-trihydroxy-3-[(1r)-6-methyl-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)phenyl]heptyl]-5-(3-methylbut-2-en-1-yl)phenyl}butan-1-one

(2r)-2-methyl-1-{2,4,6-trihydroxy-3-[(1r)-6-methyl-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)phenyl]heptyl]-5-(3-methylbut-2-en-1-yl)phenyl}butan-1-one

C39H56O8 (652.3974976000001)


   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(3-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-2-yl]methyl (4as,4bs,7s,8as,10as)-7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(3-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-2-yl]methyl (4as,4bs,7s,8as,10as)-7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

C39H56O8 (652.3974976000001)